Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 12 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

Cyclophosphamide 19 fludarabine 14 fludarabine phosphate 10 Vincristine 10 Methotrexate 9 venetoclax 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 blinatumomab 7 Whole-Body Irradiation 7 Dexamethasone 7 Cytarabine 7 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Mycophenolic Acid 5 Mesna 5 Doxorubicin 5 Calcium Dobesilate 5 ponatinib 4 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 calaspargase pegol 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡